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INTRODUCTION
The prevalence of facet joint pain is 55% in chronic cervi-
cal spine pain, 42% in thoracic spine pain, and 31% in lum-
bar spine pain (1). Various pain syndromes which produce
deep and aching pain on the C5-6 and C6-7 facet joint are
frequent in the patients who have been diagnosed originally
as myofascial pain syndrome (MPS), herniated nucleus pul-
posus (HNP), and whiplash-associated disorders (WAD).
This study was performed to compare the effects of cervical
facet joint injections for those patients who have been com-
plaining pain from cervical zygapophyseal joint. 
MATERIALS AND METHODS
Twenty patients in each group with the zygapophyseal joints
pain from C5-6 and C6-7 were classified by their origin of
pain. Inclusion criteria of chronic cervical pain syndromes
were made from their history, symptoms, and imaging diag-
nosis (Table 1). 
Patients without clear trauma history, evidence of abnormal
findings on the imaging study, and radicular pain around
neck and shoulder area were classified as MPS. 
Patients with symptom and evidence of HNP on the MRI
and/or CT and without clear history of trauma were classi-
fied as HNP. 
Patients with only trauma history without radicular pain
and abnormal findings on the imaging study were classified
as WAD. All WAD patients were selected from Grade IIa or
IIb of Quebec classification of WAD that showed musculo-
skeletal signs without neurologic symptoms.
Patients were lying down on the prone position. Under the
C-arm fluoroscopic guide, C5-6 and C6-7 zygapophyseal joints
were identified. The mixture of 0.5 mL of 1% lidocaine with
5 mg of triamcinolone was injected in the joints unilaterally
or bilaterally according to complaints of patients (Fig. 1). The
analgesic effects were evaluated by reduction of numeric rat-
ing scale (NRS) of pain before and immediately after block-
ade, and the symptom-free period in each group after the 12
months.
Statistical analysis was carried out using the SPSS ver. 10.0
for Windows software (SPSS Inc., Chicago, IL, U.S.A.). The
values were expressed as mean±the standard deviation. The
differences between groups were analyzed by ANOVA with
multiple comparisons and chi-square test, and the differences
in the group were analyzed by paired t-test.
RESULTS
The patients were at the age between 17 and 73 yr old, the
mean age was 45.5±13.3, 53.1±8.7 and 36.8±8.7 yr in
each MPS, HNP and WAD group. Male patient ratio was
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Cervical Facet Joint Injections in the Neck and Shoulder Pain
The effects from cervical facet joint injections in those patients who have been com-
plaining cervical zygapophyseal joint pain were compared. The patients were diag-
nosed originally as myofascial pain syndrome (MPS), cervical herniated nucleus pul-
posus (HNP), and whiplash-associated disorders (WAD). Patients with the zygapo-
physeal joints pain of C5-6 and C6-7 were classified by their pain origin as MPS,
HNP, and WAD. All patients had been undergone cervical zygapophyseal joints
injections with the mixture of lidocaine and triamcinolone unilaterally or bilaterally
through the posterior approach under C-arm imaging guide. The therapeutic effects
were compared with reduction of numeric rating scale (NRS) of pain before and
immediately after blockade and symptom-free periods in each group after 12 months.
Symptom durations before injections were 16.1±9.6, 4.6±1.9 and 4.1±1.1 months
in each MPS, HNP, and WAD groups. The reductions of NRS immediately after the
blockade among the three groups were not different. However, the symptom-free
duration after blockade lasted longer in the HNP group than the other two groups.
In patients with cervical zygapophyseal pain syndromes, the analgesic effect from
cervical facet joint blocks lasted longer in cervical HNP than MPS or WAD.
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30%, 60% and 55% in each MPS, HNP and WAD group. 
The symptom durations before the injections were 16.1±
9.6, 4.6±1.9 and 4.1±1.1 months in each group.
The NRS scores decreased immediately after blockade in
all the three groups, and they were not different among the
groups (3.25±0.20, 4.10±0.36 and 3.60±0.07, p>0.05).
However, the symptom-free duration after blockade last-
ed longer in the HNP group (11.3±1.7 months) than the
other two groups (MPS; 3.2±0.9, WAD; 3.0±0.8 months)
(p<0.01, Table 2).
DISCUSSION
Pain from C5-6 facet joints were focused on the top of the
shoulder region, above the level of the spine of the scapula,
occasionally lower cervical spine, whereas pain from C6-7
facet joints covers the scapular region, extending below the
spine of the scapula, mostly concentrating in the thoracic
region (2). Facet joints in the cervical spine below C2-3 are
supplied by the medial branches of the dorsal ramus above
and below the joints, which also innervate the deep parame-
dian muscles. 
Target joints were identified by the pain pattern, local or
paramedian tenderness over the area of the facet joints, and
reproduction of pain with deep pressure. Provocation of pain
from a joint is an unreliable criterion, but relief of pain is the
essential criterion (3). Therefore, the criterion of cervical facet
joint pain was relief of pain after intraarticular injection and
MPS, Myofascial pain syndrome; HNP, Herniated nucleus pulposus;
WAD, Whiplash-associated disorder according to Quebec classifica-
tion.
Imaging
diagnosis
History of radicular pain
on the shoulder and arm
Trauma history Group
MPS (-)( -)( -)
HNP (-)( + ) ( + )
WAD, grade II (+) (-)( ±)
Table 1. Inclusion criteria of chronic cervical pain syndromes
based on the history, symptoms, and the imaging study
Fig. 1. Cervical facet intraarticular injections through the posterior
approach. (A) Patients are lying down on the prone position with
a pillow. From the distance of 1 and 2 inches caudally from the
surface landmark of the spinous process of C7, 22-gauge, 10-cm
long needles were placed for aiming to the left C5-6 and right
C6-7 facet joint. The angle of the needle was dependent on the
degree of flexion of the neck and traction of the shoulder. Under
the C-arm fluoroscopic guide, contrast media were identified on
the C5-6 facet joint through the lateral view (B) and on the left C5-6
and C6-7 facet joints through the anteroposterior view (C). The
needle must be placed between inner and outer pedicular lines on
the anteroposterior view to prevent spinal cord damage or nerve
root injury. A
MPS, Myofascial pain syndrome; HNP, Herniated nucleus pulposus;
WAD, Whiplash-associated disorder. *: p<0.05 compared with HNP
and WAD group, 
� : p<0.05 compared with MPS and WAD group.
Symptom-
free period
after block-
ade (mo)
Mean reduction of
numeric rating scale
scores immediately
after blockade
Age (yr)
Symptom
duration
(mo)
Male
(%)
Group
MPS 45.5±13.3 30 16.1±9.6* 3.25±0.20 3.2±0.9
HNP 53.1±8.7 60 4.6±1.9 4.10±0.36 11.3±1.7
�
WAD 36.8±8.7 55 4.1±1.1 3.60±0.07 3.0±0.8
Table 2. Demography and results of cervical facet joint blocks
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the end of symptom relief might be the time to recur of the
previous pain disappeared by the previous blockade in this
study. 
Bogduk and associates (4) recommended medial branch
nerve blocks rather than intraarticular injections in the cer-
vical area, for the following reasons: 1) medial branch nerve
blocks are easier to perform and possibly less traumatic than
intraarticular injections; 2) the medial branch nerves lie fair-
ly superficial and are easily accessible after penetration of the
neck muscles by the needle; 3) intraarticular blocks require
skillful injection of the needle into a narrow joint space, often
after several adjustments; 4) medial branch nerve blocks can
be successfully performed in patients with facet joint disease
that has obliterated the joint space; 5) the approach to medial
branch nerve block allows the needle to remain on the dorso-
lateral aspect of the cervical spine; therefore theoretically there
is less risk of penetration of a vertebral artery, the epidural
space, or the dural sac than with intraarticular injections; and
6) no studies indicate greater therapeutic success or diagnos-
tic specificity with blockade of the medial branch innervat-
ing the facet joints. In conclusion, Bogduk et al. suggested
that medial branch nerve blocks are easy, less traumatic, and
less risky than intraarticular injections. The cervical intraar-
ticular injections with posterior approach showed a good learn-
ing curve and no chance to meet dangerous structures though
the pathway of the needle. There was no nerve trauma and
epidural puncture in this study. 
There is clear evidence why the intraarticular injections are
superior to medial nerve blocks in case of presence of inflam-
mation. Pain from nociceptive signals may result from a com-
bination of inflammatory and mechanical joint stress, possi-
bly in the presence of additional central sensitization.
The facet has extensive innervation of the synovial lining
by small C-type pain fibers. An abundance of protein gene
product 9.5 (PGP 9.5) reactive nerve fibers indicates an exten-
sive innervation of the cervical facet joint capsules. The pres-
ence of substance P (SP) and calcitonin gene-related peptide
(CGRP) reactive nerve fibers in a population of these lends
credence to the cervical facet joint capsules as a key source
of neck pain (5). 
Neuropeptides serve various functions including roles in
nociception, inflammation, vasoactivity, and tissue repair.
For the point of relief of pain, presence of SP and CGRP in
the facet joint capsules needs anti-inflammatory procedure,
even though it lasts longer or not. The protocol for diagno-
sis and treatment of cervical facet joint pain was initially the
initial intraarticular injection with local anesthetic and steroid
followed by medial branch neurotomy by conventional radio-
frequency lesioning in the recurred cases. 
The mechanical joint stress of cervical facet joints comes
from various conditions including MPS, HNP, and WAD.
The head is not perfectly balanced on top of the cervical spine.
Its weight is slightly anterior to the center of gravity, account-
ing for the large posterior cervical muscles required to hold
the head up and the rather tiny anterior neck muscles. A dis-
tance of 6 cm between the plumb line and the depth of the
cervical lordosis is considered to be normal (6). Under the per-
petuating chronic circumstances, there are postural mechani-
cal stresses on the cervical facet joints following the longstand-
ing MPS, without an imaging evidence of HNP or WAD. 
Degeneration of the disc that height lost leads to facet joint
degeneration and subsequent spinal pain (7). The peak facet
joint compression is greatest at C4-5. The peak facet joint
sliding and capsular ligament strains are largest in the lower
cervical spine, C5-6 and C6-7, and are increased with impact
acceleration (8). According to the demographic results, fre-
quent age distribution was forties, fifties, and thirties in MPS,
HNP, and WAD groups. The mean age of HNP group rep-
resenting degenerative disorder is older than that of WAD
group representing trauma. Women showed higher preva-
lence in MPS group. 
Patients diagnosed in MPS visited our clinic after long time
suffering respect to diagnosed in HNP and WAD. However,
the mean reduction of NRS scores that was measured imme-
diately after intraarticular injection of cervical facet joints did
not showed differences, the effects of injection lasted longer
in the HNP group than the other groups. The differences
would be occurred because of the longer lasting postural abnor-
mality and perpetuating factors in group MPS and because
of the associated ligament sprain, soft tissue injuries, and the
possible compensation mechanisms in group WAD.
Although the lasting effects of intraarticular injection on
the cervical facet joints are different among the groups MPS,
HNP, and WAD, the procedures were safe through the pos-
terior approach and a good diagnostic and therapeutic method.
The follow-up study about the effects for radiofrequency abla-
tion of medial branch of posterior ramus after the intraartic-
ular injection is necessary. 
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